Table 1.
Patient and Tumor Characteristics (N = 47)
| Median Age, Years (Range) | 48 (31–67) | |
|---|---|---|
| Race and Ethnicity | N | % |
| White | 35 | 74% |
| Black or African American | 12 | 26% |
| Hispanic or Latino | 2 | 4% |
| Clinical Stage | N | % |
| I | 5 | 11% |
| IIA | 10 | 21% |
| IIB | 13 | 28% |
| IIIA | 14 | 30% |
| IIIB | 2 | 4% |
| IIIC | 2 | 4% |
| IV | 1 | 2% |
| Median Tumor Diameter at Baseline, cm (Range) | 5 (1–13) | |
| Receptor Status | N | % |
| Hormone Receptor–Positive, HER2-Positive | 8 | 17% |
| Hormone Receptor–Positive, HER2-Negative | 10 | 21% |
| Hormone Receptor–Negative, HER2-Positive | 12 | 26% |
| Hormone Receptor–Negative, HER2-Negative (Triple Negative) | 17 | 36% |
| Tumor Response | N | % |
| pCR | 26 | 55% |
| Non-pCR | 18 | 38% |
| No Surgery | 3 | 6% |
Abbreviations: HER2: human epidermal receptor 2; pCR: pathologic complete response.